JULIE AHREND: Open Payments
NPI 1932667391 · LITTLE ROCK, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$531 in 17 payments from 10 companies in 2025. Trend: 2023 $1,559 · 2024 $891 · 2025 $531
Food & beverage: $500Education: $31
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 5 | $174 |
| Travere Therapeutics, Inc. | 2 | $109 |
| KYOWA KIRIN, INC. | 1 | $80 |
| OPKO Pharmaceuticals, LLC | 3 | $52 |
| Calliditas Therapeutics US Inc. | 1 | $36 |
| Lilly USA, LLC | 1 | $19 |
| Apellis Pharmaceuticals, Inc. | 1 | $17 |
| Vifor Pharma, Inc. | 1 | $16 |
| AstraZeneca Pharmaceuticals LP | 1 | $15 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $14 |
Products named: KRYSTEXXA, Filspari, RAYALDEE, TARPEYO, JARDIANCE, Veltassa, FARXIGA, Kerendia.
Industry payments across AR — which companies pay providers there.
